Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Calcagno

Showing results (61-70 of 258) with videos related to

Pageof 26
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 22, 2020
Co-infection with other respiratory pathogens in COVID-19 patientsAndrea Calcagno, Valeria Ghisetti, Elisa Burdino, et al.
AIDS Research and Human Retroviruses|March 15, 2016
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive PatientsAndrea Calcagno, Marco Simiele, Ilaria Motta, et al.
Scandinavian Journal of Infectious Diseases|June 26, 2013
Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatmentAndrea Calcagno, Lorena Baietto, Nicole Pagani, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 11, 2023
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIVMattia Trunfio, Lorenzo Mighetto, Laura Napoli, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Pharmacokinetics of the raltegravir/maraviroc/etravirine combinationAndrea Calcagno, Silvia Nozza, Stefano Bonora, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Raltegravir penetration in seminal plasma of healthy volunteersAndrea Calcagno, Stefano Bonora, Antonio D'Avolio, et al.
Frontiers in Behavioral Neuroscience|December 5, 2015
Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over TimeAlessandro Livelli, Gian Carlo Orofino, Andrea Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2013
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysisAndrea Calcagno, Jessica Cusato, Marco Simiele, et al.
Lung|September 17, 2022
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 PneumoniaMattia Trunfio, Francesca Portesani, Sabrina Vicinanza, et al.
BMC Neurology|November 17, 2021
Low cerebrospinal fluid Amyloid-βeta 1-42 in patients with tuberculous meningitisGiacomo Stroffolini, Giulia Guastamacchia, Sabrina Audagnotto, et al.
Pageof 26

Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 22, 2020
Co-infection with other respiratory pathogens in COVID-19 patientsAndrea Calcagno, Valeria Ghisetti, Elisa Burdino, et al.
AIDS Research and Human Retroviruses|March 15, 2016
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive PatientsAndrea Calcagno, Marco Simiele, Ilaria Motta, et al.
Scandinavian Journal of Infectious Diseases|June 26, 2013
Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatmentAndrea Calcagno, Lorena Baietto, Nicole Pagani, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 11, 2023
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIVMattia Trunfio, Lorenzo Mighetto, Laura Napoli, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Pharmacokinetics of the raltegravir/maraviroc/etravirine combinationAndrea Calcagno, Silvia Nozza, Stefano Bonora, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Raltegravir penetration in seminal plasma of healthy volunteersAndrea Calcagno, Stefano Bonora, Antonio D'Avolio, et al.
Frontiers in Behavioral Neuroscience|December 5, 2015
Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over TimeAlessandro Livelli, Gian Carlo Orofino, Andrea Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2013
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysisAndrea Calcagno, Jessica Cusato, Marco Simiele, et al.
Lung|September 17, 2022
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 PneumoniaMattia Trunfio, Francesca Portesani, Sabrina Vicinanza, et al.
BMC Neurology|November 17, 2021
Low cerebrospinal fluid Amyloid-βeta 1-42 in patients with tuberculous meningitisGiacomo Stroffolini, Giulia Guastamacchia, Sabrina Audagnotto, et al.
Pageof 26